Micro-X

ARPA-H Funding And US Provider Deal Will Expand Imaging Access

AnalystConsensusTarget

Not Invested

Consensus Narrative from 1 Analyst

Published

09 May 25

Updated

08 Aug 25

AnalystConsensusTarget's Fair Value

AU$0.17

54.1% undervalued

08 Aug

AU$0.078

18.2%

1.3%

Author's Valuation

AU$0.2

54.1% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates0

AnalystConsensusTarget Fair Value

AU$0.2

54.1% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

29.79%

Medical Equipment revenue growth rate

0.31%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.30%

Calculation

AU$3.45m

Earnings '28

35.80x

PE Ratio '28

AU$123.39m

Market Cap '28

AU$123.39m

Market Cap '28

587.80m

No. shares '28

AU$0.21

Share Price '28

AU$0.21 Share Price '28

Discounted to 2025 @ 7.28% p.a.

AU$0.17

Fair Value '25